Watch-list / small tactical only, ≤2% if entered — not a core holding today
Next catalyst
2026-09-29 Q1'27 earnings (Street EPS $0.45)
Single biggest risk
The turnaround stalls — brand heat, China, and DTC keep eroding while margins stay compressed
One-line thesis. NIKE is a genuinely iconic, cash-generative, cheaply-priced global brand in the middle of a real operational stumble — FY26 revenue was flat ($46.4B), EPS fell to $2.10 (from $3.83 two years ago, and FY26's number was flattered by a one-time $0.52 tariff-recovery benefit), and the stock is down ~40% in a year and ~75% from its 2021 peak. New CEO Elliott Hill and several directors are buying shares, and the balance sheet is a fortress — but until the top line and gross margin actually inflect, this is a Watch, not a Buy.
◆ Synthos call — HoldNKE is a solid business largely reflected at ~$46 — fine to keep, no reason to chase; it gets interesting again below ~$39.
Downside Risk (lower = safer)
6/10 · High
Fortress balance sheet (0.8× net-debt/EBITDA) & 3.7% yield, but earnings cut in half, -75% max drawdown, and FY26 EPS flattered by a one-time tariff benefit.
Growth Quality
3/10 · Low
Revenue flat-to-down, gross margin collapsed from ~44% to ~43%, EPS halved from $3.83 to $2.10 — a broken compounder mid-turnaround, not a grower.
Exponential Potential
2/10 · Low
No acceleration — top line is shrinking; a $65B mature apparel mega-brand with a decade of TAM behind it, not ahead. Turnaround optionality only.
⚖ Reverse-DCF cross-checkMarket-implied growth ≈ -1%/yrTo justify today’s $44, earnings would have to compound roughly -1% a year for 10 years (9% discount rate). Analysts forecast ~4%/yr, so the market is pricing in LESS than what the Street expects.What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.
In plain English
NIKE makes the sneakers and athletic gear you see everywhere — the Swoosh, Air Jordan, Converse. It is one of the most recognized brands on earth. The problem is that the business has been going backwards: sales stopped growing, and profit per share has been roughly cut in half over two years. The stock has fallen a lot as a result — it is down about 40% in the past year.
Is it cheap? Sort of. It looks cheap on last year's profit, but last year's profit was boosted by a one-time tariff refund, so on a "clean" basis it is only moderately cheap for a company whose earnings are still falling. You are paying for a recovery that hasn't happened yet.
Our verdict is Watch — meaning keep an eye on it, don't rush in. The company has a rock-solid balance sheet, pays a ~3.7% dividend, and a brand-new CEO plus several board members have been buying the stock with their own money (a good sign). But we want to see the numbers turn before calling it a Buy.
Here's what our three scores mean in everyday terms:
Downside Risk 6/10 (a bit elevated). Financially the company is very safe (little debt, big cash pile), but the stock has already fallen hard, earnings are still dropping, and last year's profit was propped up by a one-off — so there's real risk the recovery disappoints.
Growth Quality 3/10 (poor, for now). The business is shrinking, not growing, and profit margins have squeezed. This is a repair job, not a growth story.
Exponential Potential 2/10 (very low). This is a huge, mature company. Even in a good outcome it recovers to old profits — it is not going to multiply several times over.
The one big worry: the turnaround simply doesn't take. If brand momentum, China, and NIKE's own online store keep sliding while margins stay squeezed, the "cheap" stock can stay cheap or get cheaper.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Relative performance vs S&P 500 & its sector (XLY (sector)), set to 100 a year ago
Solid = NKE · dashed = S&P 500 · dotted = XLY (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
Price$44.09
Market cap$65B
P/E trailing2×
P/E FY26E / FY27E29× / 25×
EV / Sales1.5×
EV / EBITDA15.2×
Gross margin42.9%
Net margin6.7%
Dividend yield3.70%
Beta1.128
52-wk range$41 – $79
RSI(14)42
50 / 200-DMA$44 / $57
12-mo return+-40% (SPY +21%)
Street target$53 ($35–$75)
Analyst grades34 Buy · 31 Hold · 5 Sell
FMP ratingB+
Next earnings2026-08-05
What the experts actually said 2 traceable claims on NKE · showing the highest-conviction voices
“Brand bet plus Caitlyn Clark as future female Jordan; insider buying; down four straight years, worst stretch ever may mark bottom.”
Compound And Friendsbullishconviction 602026-01-02compound_and_friends-TLMfVxCP5-U:322095460d
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
1. What it is
NIKE, Inc. (NYSE: NKE) is the world's largest designer, marketer and distributor of athletic footwear, apparel, equipment and accessories, founded in 1964 (as Blue Ribbon Sports) and headquartered in Beaverton, Oregon. The franchise spans the NIKE Brand (including Jordan) plus the wholly-owned Converse subsidiary. It sells through wholesale partners and its own direct channel (NIKE Direct — owned stores plus digital). Fiscal year ends May 31; FY26 just closed 2026-05-31.
Revenue mix (FY2025, from filings — FMP segmentation):
By product: Footwear $30.97B (66%) · Apparel $15.27B (33%) · Equipment/other ~$0.07B. Footwear is the profit engine and the brand.
By geography: North America $19.57B (42%) · EMEA $12.26B (26%) · Greater China $6.59B (14%) · Asia Pacific & Latin America $6.25B (13%). Greater China is the swing factor — the highest-margin growth region historically, now the biggest drag.
By channel (FY26, from the earnings release): Wholesale $27.5B (+6% reported) · NIKE Direct $17.7B (−6% reported, with Digital −12%). The DTC pivot that management championed in 2020–2022 is now unwinding, and rebuilding wholesale relationships is a core plank of the turnaround.
The strategic story is a classic turnaround under a returning insider CEO (Elliott Hill, a 30-year NIKE veteran who came back in late 2024): re-ignite sport-led product innovation ("Sport Offense"), fix the over-rotation into DTC/digital, clear aged inventory, and re-earn brand heat lost to On, Hoka (Deckers) and New Balance.
2. The expert thesis — thin coverage (traceable)
Honest disclosure: NIKE has very shallow coverage in the Synthos KB — 2 total claims, 1 net-bullish voice, net conviction +0.6. This is not a high-conviction, broadly-corroborated expert call like our flagship names. The verdict here is primarily fundamentals- and quant-driven, with the single expert voice as color, not backbone.
The one bullish voice — a turnaround/"bottom" bet.Compound and Friends (compound_and_friends-TLMfVxCP5-U:322095460d, bullish, conviction 60, skill 1.0, dated 2026-01-02): a brand bet plus Caitlin Clark as a potential "future female Jordan"; insider buying; the stock down four straight years — its worst stretch ever — may mark the bottom. This is explicitly a mean-reversion/turnaround thesis, not a growth thesis, and it is honest about why (four down years).
That is the entire expert file. No cautionary voice is recorded, so the KB does not itself supply the bear case — we build it from the fundamentals below. Treat the conviction rating as Low and weight the quant and financial evidence accordingly.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
Score
0–10
The read
Downside Risk(lower = safer)
6 · Elevated
Balance sheet is a fortress (net-debt/EBITDA 0.77×, $9.0B cash, 3.7% yield, beta 1.13), but earnings have halved, FY26 EPS was flattered by a one-time $0.52 tariff-recovery benefit, the stock is in a −75% max drawdown from its 2021 peak, and it's cyclical/discretionary. Cheap-ish, but "value trap" risk is live.
Growth Quality
3 · Poor (for now)
FY26 revenue flat / −2% currency-neutral; gross margin ~42.9% (down from ~44–46% at peak); EPS $2.10 vs $3.83 in FY22. ROE 22% flatters a shrinking-equity base; ROIC ~11%. A broken compounder mid-repair, not a grower.
Exponential Potential
2 · Low
Top line is contracting, not accelerating. A $65B mature global apparel brand whose TAM it already saturates. Best case is recovery to prior earnings, not a multibagger. Turnaround optionality only.
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is the expected path, and the cases bound the range. Note NIKE's earnings are depressed, so multiples look optically high — the honest anchor is normalized earnings power, not this year's trough.
Case
Key assumptions
Fair value
Bull
Turnaround works: brand heat returns, wholesale rebuild + China stabilizes, gross margin recovers toward ~46%. Earnings power normalizes to ~$3.40 EPS by FY29 (roughly FY29–30 estimate path); market pays ~20× for a re-accelerating iconic brand.
~$68 (+54%)
Base(our anchor)
Slow, choppy recovery. FY27E EPS $1.75 troughs, FY28E recovers to ~$2.20; the market looks through to a ~$2.30–2.50 normalized number and pays ~19–20× a quality brand with a fortress balance sheet + 3.7% yield.
~$46 (+4%)
Bear
Turnaround stalls — DTC/digital keeps bleeding, China stays weak, tariffs/promotions pressure gross margin, brand share continues leaking to On/Hoka/NB. EPS stuck near ~$1.75–2.00; multiple de-rates to ~15× on a "value trap" tag.
~$30 (−32%)
Synthos fair value = the base case, ~$46 (+4%), with the full $30–$68 span as the honest range. Our base sits below the Street's $53.35 consensus — we are less willing than the Street to underwrite the recovery before it shows in the numbers. This is a near-fairly-valued, show-me situation: the asymmetry isn't compelling enough today to override the still-falling fundamentals, which is exactly why the verdict is Watch, not Buy. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating multi-baggers-from-here). NKE is neither today — it is a broken compounder in repair:
Forward growth: revenue is flat-to-declining now — FY26 $46.4B was flat reported (−2% currency-neutral). Consensus has revenue essentially flat FY27 (~$45.8B) before a modest recovery to ~$47–48B by FY28–29. This is stabilization, not growth.
Acceleration (the 2nd derivative) is negative-to-zero: revenue went from $51.4B (FY24) → $46.3B (FY25) → $46.4B (FY26). EPS: $3.83 (FY22) → $3.76 (FY24) → $2.17 (FY25) → $2.10 (FY26, and that includes a one-time $0.52 tariff-recovery benefit). The trend is down, then flat. There is no exponential here — the acceleration term is the wrong sign.
Room to run: at $65B market cap in a mature ~$400B global sportswear category NIKE already leads, the "room" is recovery to prior peak earnings, not a new S-curve. Per our flagship philosophy we pick forward next-exponentials over trailing/decelerating names — NKE is on the wrong side of that test.
Reinvestment runway: modest — capex is only ~$0.4–0.8B/yr; this is a brand and working-capital business, and the buyback (now throttled to $123M in FY26 vs $4B+ historically) is preserving cash during the repair.
Exponential Potential: Low (2/10). Own NKE — if at all — for a cyclical recovery + brand-durability + dividend thesis, explicitly not for exponential growth. A small, accelerating challenger (On at ~$12B, decelerating-but-growing) would score far higher on this axis; NKE is the incumbent being disrupted.
Revenue: FY26 $46.40B, flat reported / −2% currency-neutral (FY25 $46.31B, FY24 $51.36B). The two-year top line is down ~10%.
Quarterly trajectory (FY26): Q1 $11.72B → Q2 $12.43B → Q3 $11.28B → Q4 $10.97B (−1% reported, −4% currency-neutral). Still declining into year-end; no clean inflection yet.
Margins: gross 42.9% FY26 (up a scant 20bp for the year, but Q4 gross jumped to 49.2% only because of a one-time ~$986M IEEPA tariff-recovery benefit — ~900bp; strip that and Q4 gross was ~40%). Operating margin ~8.2%, net margin 6.7% TTM — roughly half the ~11–12% net margin of NIKE's prime.
Earnings: net income $3.11B FY26 (−3% YoY), EPS $2.10 (−3%). Critically, FY26 EPS includes a $0.52/share IEEPA tariff-recovery benefit — underlying operating EPS was closer to ~$1.55–1.60, i.e. earnings power is weaker than the headline.
Cash flow: FY25 operating CF $3.70B, capex −$0.43B, FCF $3.27B (FCF fell sharply from $6.6B in FY24 as earnings compressed and working capital turned). FCF yield is thin (~1.6% on the trough).
Balance sheet: cash + ST investments $9.03B, total debt $11.0B, net debt only $3.47B, net-debt/EBITDA 0.77× — investment-grade, easily serviceable, ample dividend cover. This fortress is the main reason downside is bounded rather than existential.
6. Valuation — cheap, or a value trap?
On trailing numbers NKE looks moderately cheap: 21× EPS, 1.5× sales, 15× EV/EBITDA, 3.7% dividend yield — well below its own historical 25–35× P/E. But two honest caveats gut the "obviously cheap" read:
1. The E is depressed and flattered. FY26 EPS $2.10 includes a one-time $0.52 tariff-recovery benefit; underlying is ~$1.55–1.60. On forward consensus the multiple actually rises: ~30× FY27E ($1.75), falling to ~20× FY28E ($2.20) only as earnings recover. So the stock is not cheap on the earnings the business is currently producing — it's cheap only if you believe in the recovery.
2. The whole call is normalization. The bull case rests on earnings power returning toward $3+ (last seen FY22–24). Pay ~19–20× a normalized ~$2.30–2.50 and you get roughly today's price — i.e. the market is already paying a fair price for the recovery, leaving limited margin of safety.
Reverse read: at $44 the market is pricing a gradual return to ~$2.30–2.60 normalized EPS at a ~18–20× multiple — a credible but un-de-risked base. Street targets (context): consensus $53.35, high $75, low $35 — the Street is more optimistic than we are, and its own wide 35→75 range signals how binary the turnaround is. Our $46 base is deliberately below consensus: not a value buy yet; a show-me situation. NIKE's own letter rating is B+ (FMP), consistent with quality-but-not-cheap-enough.
7. Technicals (computed from EOD price history)
Trend:down. $44.09 sits below the 200-DMA ($57.32) and right at the 50-DMA ($43.84) — the 50 is well below the 200 (death-cross posture). MACD −0.61 (negative).
Location:−44% off the 52-week high ($79.24), only +8% off the 52-week low ($40.75) — bumping along near the lows. The max drawdown from the 2021 all-time peak is −75% — this has been a brutal multi-year de-rate.
Momentum: RSI(14) 42 — neither oversold nor showing upside thrust; a listless, base-building tape at best.
Relative strength (the tell): NKE −40% 12-mo vs SPY +21% and QQQ +30%; −28% 6-mo vs SPY +8%. Persistent, severe underperformance of both the market and tech — a falling knife that has not yet demonstrated a trend change.
Read: technicals do not confirm a bottom. Price is below the falling 200-DMA with negative MACD. A base-and-reclaim of the 200-DMA (~$57) would be the first real technical evidence the turnaround is being priced — until then the tape says wait, which aligns with the Watch verdict.
8. Moat & competitive position
NIKE's moat is one of the strongest brands in consumer history — the Swoosh, Jordan, decades of athlete endorsements, unmatched global distribution and scale. That is durable and real; it is why the balance sheet and cash generation survive a demand air-pocket. But brand moats in apparel are not impregnable — they depend on cultural relevance, and NIKE has visibly lost share of heat to On and Hoka (Deckers) in performance running, to New Balance in lifestyle, and ceded shelf momentum by over-rotating into its own DTC/digital channel and pulling back from wholesale (now being reversed). Greater China — historically the highest-margin growth engine — has also structurally weakened (local brands, macro).
Peer set (market cap): Amer Sports $20.3B, ASICS $19.6B, Deckers (Hoka/UGG) $14.5B, Lululemon $13.4B, On Holding $12.3B, Skechers $9.5B, PUMA $4.5B, V.F. Corp $6.4B, Under Armour $2.8B. NKE at $65B dwarfs them all in scale — the disruption is at the margin (incremental share, not existential), which is precisely why this is a turnaround, not a terminal-decline, story. The competitive question that decides the thesis: can NIKE re-take performance-running and lifestyle mindshare from smaller, faster, currently-hotter brands?
9. Management, capital allocation & guidance
Capital allocation: conservative and shareholder-friendly through the downturn — FY26 returned ~$2.5B ($2.4B dividends, up 5%; buybacks throttled to just $123M vs $4B+ historically to preserve cash during the repair). Dividend (~3.7% yield) looks well-covered by FCF and the cash pile. Capex is light (~$0.4–0.8B/yr).
Insider activity — a genuine positive signal. Unlike routine 10b5-1 selling, NIKE has seen open-market director/CEO buying: CEO Elliott Hill purchased ~23,660 shares at ~$42.27 (2026-04-13), director Tim Cook bought 25,000 shares at ~$42.43 (2026-04-10), and director John W. Rogers bought 4,000 at ~$43.34 (2026-04-09). Insiders putting personal capital in near current levels corroborates the Compound and Friends "insider buying / possible bottom" thesis (compound_and_friends-TLMfVxCP5-U:322095460d). (Some routine F-InKind tax withholdings and a gift also appear in the window — those are neutral.)
Management's own guidance (the earnings-call track, half-weighted — they talk their book): the FY26 Q4 release (SEC 8-K, filed 2026-06-30) is a real earnings release and confirms the operating picture but contains no explicit forward revenue/EPS guidance figures in the prepared text. CEO Elliott Hill framed FY26 as taking "decisive actions to strengthen the foundation… and reposition our business for long-term growth," while acknowledging "top-line headwinds" and focusing on "improved profitability." CFO Matthew Friend cited "an increasingly challenging operating environment, where sell-through remains challenged."Net: management is signaling a multi-quarter repair, not an imminent re-acceleration — and offered no hard numeric guide. Treat this as directional, self-interested, and half-weighted.
10. Catalysts & what to watch
Next earnings: 2026-09-29 (Q1'27; Street EPS $0.45, revenue ~$11.4B). The key lines: currency-neutral revenue trend (does it stop declining?), gross margin ex-tariff-noise, and NIKE Direct / Digital (does the −12% digital bleed slow?).
Greater China: stabilization vs further deterioration — the single biggest regional swing.
Wholesale rebuild: evidence the re-engagement with wholesale partners is driving sell-in and shelf space back.
Inventory & gross margin: clean (ex-tariff) gross-margin recovery toward mid-40s is the tell the repair is working.
Brand heat: performance-running share vs On/Hoka; the Caitlin Clark / women's-sport bet (per the KB thesis) actually converting to revenue.
Thesis tripwires (what would move us off Watch):Toward Buy — two consecutive quarters of currency-neutral revenue growth and ex-tariff gross margin recovering toward mid-40s. Toward Avoid — another leg down in China + continued Digital declines + gross margin failing to recover, i.e. the turnaround stalling with the stock a confirmed value trap.
11. Key risks
Turnaround execution (the core risk): the entire bull case is a repair that hasn't shown in the numbers yet. Revenue is still declining currency-neutral; EPS is still falling ex-one-offs.
Earnings quality flag: FY26 EPS $2.10 is flattered by a one-time ~$0.52 IEEPA tariff-recovery benefit — underlying earnings power (~$1.55–1.60) is weaker than the headline, so the stock is dearer than it looks.
China / geographic concentration: Greater China (14% of revenue, historically top-margin) is a structural drag; macro and local-brand competition may not reverse.
Brand-share erosion: On, Hoka, New Balance continue taking mindshare in the categories that matter (running, lifestyle) — an apparel brand moat can keep leaking.
Cyclicality / discretionary demand: beta 1.13; a consumer slowdown or tariff escalation hits a company already operating below its margin potential.
Value-trap risk: cheap-looking multiples on depressed earnings can stay cheap for years if the fundamental inflection never arrives.
Thin conviction: only 1 expert voice and 2 KB claims — low external corroboration; the call leans on fundamentals/quant.
12. Verdict, position sizing & monitoring
Watch. NIKE is a genuinely iconic, fortress-balance-sheet, cash-generative global brand trading ~40% below last year and ~75% below its 2021 peak, with a returning-insider CEO and real open-market insider buying (Hill, Cook, Rogers near $42–43) — the ingredients of a classic turnaround. But the fundamentals have not inflected: FY26 revenue was still down currency-neutral, EPS fell to $2.10 (and even that was propped up by a one-time tariff benefit), gross margin is depressed, and the technicals are in a confirmed downtrend below a falling 200-DMA. Our base-case fair value (~$46) sits below the Street's $53.35, so the risk/reward is roughly balanced — not the asymmetric setup that earns a Buy. The honest call is to wait for the numbers to turn.
Sizing:Watch-list first. For investors who want the turnaround exposure anyway, keep it small and tactical (≤2%) with the ~3.7% dividend paying you to wait — not a core position until an inflection is visible.
Monitoring: re-underwrite on the §10 tripwires; formal re-score at the 2026-09-29 print. Two clean quarters of currency-neutral growth + ex-tariff margin recovery would move this toward Buy — Tactical; a China/Digital relapse would move it toward Avoid. Logged as a tracked Synthos call as of 2026-07-03 at $44.09.
Single biggest risk: the turnaround stalls — brand heat, China, and DTC keep eroding while margins stay compressed, and the cheap stock stays cheap.
Provenance & disclosures
Traceability: 2 KB claims, breadth 1 net-bullish voice, net conviction +0.6, last claim 2026-01-02 — the one cited (compound_and_friends-TLMfVxCP5-U:322095460d) reconciles to a real claim_id. Coverage is thin; the verdict is primarily fundamentals- and quant-driven, and we say so plainly. Fabricated conviction is structurally impossible (claim-ID reconciliation).
Data as-of: fundamentals 2026-05-31 (FY26, ended May 2026) · estimates & prices 2026-07-02/03 · expert claims through 2026-01-02. Forward figures are analyst consensus (FMP), labeled as estimates. Note the outer-year estimates (FY29–30) rest on very few analysts (1–4) and should be treated as low-confidence.
Management caveat: the FY26 Q4 earnings release (SEC 8-K, 2026-06-30) is a real release but contains no explicit numeric forward guidance; management commentary is directional, self-interested, and half-weighted by design.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").